Ingenix

About Ingenix

Ingenix develops proprietary multimodal and multiscale generative AI to act as a co-pilot for clinical development. Its platform enables accurate simulation of clinical trials on digital twins, integrating knowledge from molecular to population levels. The system processes text, graphics, bioimaging, 3D structures, sequences, and time-series data to predict clinical endpoints and adverse events. Based in the biotech sector, Ingenix targets pharmaceutical research and development to accelerate drug discovery and precision medicine.